Clinical
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Intrathecal Version of Zolgensma, Ozempic Falls Short in EVOKE Trials, Asundexian Meets End Point in Stroke Prevention Trial
2
FDA Reverses Course on AMT-130, Citing Insufficient External Data for Submission
3
Insight the Future of Anti-Tau Drug Development for Alzheimer Disease
4
Evaluating GLP-1 Receptor Agonist Semaglutide in Phase 3 Settings for Alzheimer Disease: The EVOKE Trials
5
